MEDIUMFDA DRUG

Taro Pharmaceuticals Withdraws Diclofenac Sodium Gel Over Viscosity Issues

Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
June 1, 2026
Status
ACTIVE
Severity
4/10

Quick Facts at a Glance

Recall Date
June 1, 2026
Hazard Level
MEDIUM
Brand
BEEKEEPER'S NATURALS USA
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
BEEKEEPER'S NATURALS USA
Product type
Topical Gel
Model numbers
Lot #: 5950, Exp. Date 02/2028
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    June 1, 2026

  2. Reported by FDA DRUG

    June 17, 2026

  3. RecallRadar source check

    June 24, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Microbial Contamination of Non-Sterile Products

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact BEEKEEPER'S NATURALS USA INC. or your healthcare provider for guidance. Notification method: Letter

About This Product

Diclofenac Sodium, Topical Gel, 3% is a prescription medication used to relieve pain and inflammation. Consumers typically buy it for conditions like arthritis and muscle pain.

Why This Is Dangerous

The product's viscosity not meeting specifications means it may not deliver the intended therapeutic effects. This could lead to insufficient pain relief for users relying on this medication.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Consumers may experience inconvenience due to the need to stop using the product and seek alternatives for pain management.

Practical Guidance

How to identify if yours is affected

  1. Check the lot number on your product packaging against AD92720, AD92722, and AD92723.
  2. Verify the expiration date; affected products expire on March 31, 2027.
  3. Consult your healthcare provider if unsure about your product.

Where to find product info

Lot numbers are typically printed on the side of the tube or on the box packaging.

What timeline to expect

Expect a refund or replacement process to take 4-6 weeks once the company is contacted.

If the manufacturer is unresponsive

  • Document all correspondence with Sun Pharmaceutical.
  • Contact your healthcare provider for further guidance.
  • Consider reaching out to the FDA if you receive no response.

How to prevent similar issues

  • Always check for recalls before using medications.
  • Consult your doctor about any concerns regarding medication effectiveness.
  • Look for FDA approval and check specifications before purchase.

Documentation advice

Keep receipts, lot numbers, and any correspondence with the manufacturer or healthcare provider for your records.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

The affected product is Diclofenac Sodium, Topical Gel, 3% in 100 g tubes. It was manufactured by Taro Pharmaceuticals Inc. in Brampton, Ontario, Canada. Lot numbers include AD92720, AD92722, and AD92723, with an expiration date of March 31, 2027.

Key Facts

  • Market withdrawal initiated on January 27, 2026
  • Product does not meet viscosity specifications
  • No reported injuries related to this withdrawal
  • Stop using the product immediately

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelMEDIUM
Severity Score
4/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Lot #: 5950
Exp. Date 02/2028
Affected States
ALL
Report Date
June 17, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more